EMAIL THIS PAGE TO A FRIEND

Cancer letters

N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.


PMID 25153349

Abstract

Although NDRG2 has recently been found to be a candidate tumor suppressor, its precise role in the epithelial-mesenchymal transition (EMT) is not well understood. In the present study, we demonstrated that NDRG2 overexpression in MDA-MB-231 cells down-regulated the expression of Snail, a transcriptional repressor of E-cadherin and a key regulator of EMT, as well as the phosphorylation of signal transducer and activator of transcription 3 (STAT3), an oncogenic transcription factor that is activated in many human malignancies including breast cancer. In addition, we confirmed that the expression of Snail and phospho-STAT3 was recovered when NDRG2 was knocked down by siRNA in MCF7 cells in which NDRG2 is endogenously expressed. Interestingly, MDA-MB-231-NDRG2 cells showed remarkably decreased Snail expression after treatment with JSI-124 (also known as cucurbitacin I) or Stattic, STAT3 inhibitors, compared to MDA-MB-231-mock cells. Moreover, STAT3 activation by EGF treatment induced higher Snail expression, and NDRG2 overexpression resulted in the inhibition of Snail expression in MDA-MB-231 cells stimulated by EGF in the absence or presence of STAT3 inhibitor. Treatment of MDA-MB-231 cells with STAT3 inhibitor led to a moderate decrease in wound healing and migration capacity, whereas STAT3 inhibitor treatment of MDA-MB-231-NDRG2 cells resulted in a significant attenuation of migration in both resting and EGF-stimulated cells. Collectively, our data demonstrate that the inhibition of STAT3 signaling by NDRG2 suppresses EMT progression of EMT via the down-regulation of Snail expression.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2501708
Anti-NDRG2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1409568
Anti-NDRG2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA002896
Anti-NDRG2 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV47976
Anti-NDRG2 antibody produced in rabbit, affinity isolated antibody
HPA003590 Anti-NDRG2 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106795
Anti-NDRG2 antibody produced in rabbit, affinity isolated antibody
SAB1411146
Anti-NDRG2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4504540
Anti-phospho-STAT3 (pSer727) antibody produced in rabbit, affinity isolated antibody
EHU122051 MISSION® esiRNA, esiRNA human STAT3 (esiRNA1)
EHU066241 MISSION® esiRNA, esiRNA human NDRG2 (esiRNA1)
EMU082481 MISSION® esiRNA, esiRNA targeting mouse Stat3 (esiRNA1)
WH0057447M3
Monoclonal Anti-NDRG2 antibody produced in mouse, clone 6A5, purified immunoglobulin, buffered aqueous solution
SAB1409567
Monoclonal Anti-NDRG2 antibody produced in mouse, clone 1D6, purified immunoglobulin, buffered aqueous solution
SAB1405208
Monoclonal Anti-NDRG2, (N-terminal) antibody produced in mouse, clone 1D12, purified immunoglobulin, buffered aqueous solution